Evidence map›Paper›PMID 41938712›Full record

ReviewGenes & diseases2026

Crosstalk between autophagy and ferroptosis in diabetes.

Erlian Xie, Xuerong Wei, Zijun Zheng, Qiuyi Yu, Mengqian Liu, Huihui Zhang, Ziwei Jiang, Yanbin Gao, Lei Yang

Abstract readReview
In one paragraph

Review in Genes & diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Erlian XieDepartment of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Xuerong WeiDepartment of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Zijun ZhengDepartment of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Qiuyi YuDepartment of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Mengqian LiuDepartment of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Huihui ZhangDepartment of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Ziwei JiangDepartment of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Yanbin GaoDepartment of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Lei YangDepartment of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes is a multifactorial metabolic disease involving complex disruptions in cellular homeostasis and multiple forms of regulated cell death. Among them, the interaction between autophagy and ferroptosis has recently gained increasing attention. Autophagy is a catabolic process essential for degrading damaged organelles and misfolded proteins, thus preserving cellular integrity. Ferroptosis, on the other hand, is a newly identified, iron-dependent form of cell death characterized by excessive lipid peroxidation. Emerging evidence suggests that these two processes are intricately linked through shared regulatory pathways involving iron metabolism, lipid homeostasis, and the antioxidant system. Their crosstalk plays crucial roles in key diabetic pathologies, including pancreatic β-cell dysfunction, insulin resistance, and vascular complications. This review provides a comprehensive overview of the molecular mechanisms underlying autophagy-ferroptosis interactions in diabetes and highlights how their cooperative or antagonistic actions contribute to disease progression. Additionally, we discuss novel therapeutic strategies aimed at modulating this interplay, which may offer promising avenues for improving outcomes in diabetes and its complications. Further studies are needed to define precise molecular targets and facilitate clinical translation.

Indexed as

AutophagyCo-mechanismDiabetes mellitusDiabetic complicationsFerroptosis

Identifiers

PMID41938712
PMCPMC13050090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.